Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 65

1.

Impact of rifaximin therapy on ischemia reperfusion injury in liver transplantation: a propensity score-matched analysis.

Ito T, Nakamura K, Kageyama S, Korayem IM, Hirao H, Kadono K, Aziz J, Younan S, DiNorcia J 3rd, Agopian VG, Yersiz H, Farmer DG, Busuttil RW, Kupiec-Weglinski JW, Kaldas FM.

Liver Transpl. 2019 Sep 11. doi: 10.1002/lt.25633. [Epub ahead of print]

PMID:
31509643
2.

Antibiotic pretreatment alleviates liver transplant damage in mice and humans.

Nakamura K, Kageyama S, Ito T, Hirao H, Kadono K, Aziz A, Dery KJ, Everly MJ, Taura K, Uemoto S, Farmer DG, Kaldas FM, Busuttil RW, Kupiec-Weglinski JW.

J Clin Invest. 2019 Jul 22;129(8):3420-3434. doi: 10.1172/JCI127550. eCollection 2019 Jul 22.

3.

Heme Oxygenase-1 dictates innate - adaptive immune phenotype in human liver transplantation.

Kadono K, Dery KJ, Hirao H, Ito T, Kageyama S, Nakamura K, Oncel D, Aziz A, Kaldas FM, Busuttil RW, Kupiec-Weglinski JW.

Arch Biochem Biophys. 2019 Aug 15;671:162-166. doi: 10.1016/j.abb.2019.07.007. Epub 2019 Jul 9.

PMID:
31299184
4.

The Abdominal Transplant Surgery Workforce: Current state and future trends.

Kaldas FM, Rocca JP, Bhati CS, Duan N, Evenson AR, Tan HP, Redfield RR, di Sabato DM, Yoshida A, Abt PL, Geevarghese SK.

Clin Transplant. 2019 Jul 6:e13659. doi: 10.1111/ctr.13659. [Epub ahead of print]

PMID:
31278776
5.

Transjugular Liver Biopsy: Safe Even in Patients With Severe Coagulopathies and Multiple Biopsies.

Sue MJ, Lee EW, Saab S, McWilliams JP, Durazo F, El-Kabany M, Kaldas F, Busuttil RW, Kee ST.

Clin Transl Gastroenterol. 2019 Jul;10(7):e00063. doi: 10.14309/ctg.0000000000000063.

6.

Factors predicting kidney delayed graft function among recipients of simultaneous liver-kidney transplantation: A single-center experience.

Korayem IM, Agopian VG, Lunsford KE, Gritsch HA, Veale JL, Lipshutz GS, Yersiz H, Serrone CL, Kaldas FM, Farmer DG, Bunnapradist S, Danovitch GM, Busuttil RW, Zarrinpar A.

Clin Transplant. 2019 Jun;33(6):e13569. doi: 10.1111/ctr.13569. Epub 2019 May 7.

7.

Assessment of Anastomotic Biliary Complications in Adult Patients Undergoing High-Acuity Liver Transplant.

Kaldas FM, Korayem IM, Russell TA, Agopian VG, Aziz A, DiNorcia J, Farmer DG, Yersiz H, Hiatt JR, Busuttil RW.

JAMA Surg. 2019 May 1;154(5):431-439. doi: 10.1001/jamasurg.2018.5527.

PMID:
30758485
8.

Pattern Recognition Receptor-reactivity Screening of Liver Transplant Patients: Potential for Personalized and Precise Organ Matching to Reduce Risks of Ischemia-reperfusion Injury.

Sosa RA, Rossetti M, Naini BV, Groysberg VM, Kaldas FM, Busuttil RW, Chang YL, Gjertson DW, Kupiec-Weglinski JW, Reed EF.

Ann Surg. 2018 Nov 22. doi: 10.1097/SLA.0000000000003085. [Epub ahead of print]

PMID:
30480558
9.

Metabolic factors affecting hepatocellular carcinoma in steatohepatitis.

Zarrinpar A, Faltermeier CM, Agopian VG, Naini BV, Harlander-Locke MP, Kaldas FM, Farmer DG, Busuttil RW.

Liver Int. 2019 Mar;39(3):531-539. doi: 10.1111/liv.14002. Epub 2018 Dec 2.

10.

Minimizing central line-associated bloodstream infections in a high-acuity liver transplant intensive care unit.

Russell TA, Fritschel E, Do J, Donovan M, Keckeisen M, Agopian VG, Farmer DG, Wang T, Rubin Z, Busuttil RW, Kaldas FM.

Am J Infect Control. 2019 Mar;47(3):305-312. doi: 10.1016/j.ajic.2018.08.006. Epub 2018 Oct 15.

PMID:
30333081
11.

Practical methods for effective vancomycin-resistant enterococci (VRE) surveillance: experience in a liver transplant surgical intensive care unit.

Linfield RY, Campeau S, Injean P, Gregson A, Kaldas F, Rubin Z, Kim T, Kunz D, Chan A, Lee DJ, Humphries RM, McKinnell JA.

Infect Control Hosp Epidemiol. 2018 Oct;39(10):1178-1182. doi: 10.1017/ice.2018.178. Epub 2018 Sep 4.

PMID:
30178725
12.

Recipient HO-1 inducibility is essential for posttransplant hepatic HO-1 expression and graft protection: From bench-to-bedside.

Kageyama S, Hirao H, Nakamura K, Ke B, Zhang M, Ito T, Aziz A, Oncel D, Kaldas FM, Busuttil RW, Sosa RA, Reed EF, Araujo JA, Kupiec-Weglinski JW.

Am J Transplant. 2019 Feb;19(2):356-367. doi: 10.1111/ajt.15043. Epub 2018 Aug 24.

PMID:
30059195
13.

Heart and heart-liver transplantation in adults with failing Fontan physiology.

Reardon LC, DePasquale EC, Tarabay J, Cruz D, Laks H, Biniwale RM, Busuttil RW, Kaldas FM, Saab S, Venick RS, Lin JP, Nsair A, Deng MC, Ardehali A, Caderias M, Iygengar A, Aboulhosn JA.

Clin Transplant. 2018 Aug;32(8):e13329. doi: 10.1111/ctr.13329. Epub 2018 Jul 18.

PMID:
29947122
14.

Coil-Assisted Retrograde Transvenous Obliteration (CARTO): An Alternative Treatment Option for Refractory Hepatic Encephalopathy.

Lee EW, Saab S, Kaldas F, Fletcher S, Busuttil RW, Durazo F, McWilliams JP, DiNorcia J 3rd, Padia SA, Kee ST.

Am J Gastroenterol. 2018 Aug;113(8):1187-1196. doi: 10.1038/s41395-018-0109-5. Epub 2018 Jun 14.

PMID:
29899437
15.

Survival Outcomes After Intracranial Hemorrhage in Liver Disease.

Lagman C, Nagasawa DT, Azzam D, Sheppard JP, Chen CHJ, Ong V, Nguyen T, Prashant GN, Niu T, Tucker AM, Kim W, Kaldas FM, Pouratian N, Busuttil RW, Yang I.

Oper Neurosurg (Hagerstown). 2019 Feb 1;16(2):138-146. doi: 10.1093/ons/opy096.

PMID:
29767779
16.

A novel multimarker assay for the phenotypic profiling of circulating tumor cells in hepatocellular carcinoma.

Court CM, Hou S, Winograd P, Segel NH, Li QW, Zhu Y, Sadeghi S, Finn RS, Ganapathy E, Song M, French SW, Naini BV, Sho S, Kaldas FM, Busuttil RW, Tomlinson JS, Tseng HR, Agopian VG.

Liver Transpl. 2018 Jul;24(7):946-960. doi: 10.1002/lt.25062.

17.

Case Report: First Reported Combined Heart-Liver Transplant in a Patient With a Congenital Solitary Kidney.

Hanna RM, Kamgar M, Hasnain H, Khorsan R, Nsair A, Kaldas F, Baas A, Bunnapradist S, Wilson JM.

Transplant Proc. 2018 Apr;50(3):943-946. doi: 10.1016/j.transproceed.2017.11.030. Epub 2018 Feb 16.

PMID:
29458999
18.

End-Stage Liver Disease in Patients with Intracranial Hemorrhage Is Associated with Increased Mortality: A Cohort Study.

Lagman C, Nagasawa DT, Sheppard JP, Jacky Chen CH, Nguyen T, Prashant GN, Niu T, Tucker AM, Kim W, Pouratian N, Kaldas FM, Busuttil RW, Yang I.

World Neurosurg. 2018 May;113:e320-e327. doi: 10.1016/j.wneu.2018.02.025. Epub 2018 Feb 13.

PMID:
29452322
19.

One Thousand Pediatric Liver Transplants During Thirty Years: Lessons Learned.

Venick RS, Farmer DG, Soto JR, Vargas J, Yersiz H, Kaldas FM, Agopian VG, Hiatt JR, McDiarmid SV, Busuttil RW.

J Am Coll Surg. 2018 Apr;226(4):355-366. doi: 10.1016/j.jamcollsurg.2017.12.042. Epub 2018 Feb 2.

PMID:
29410290
20.

Optimizing the Management of Abnormal Liver Function Tests after Orthotopic Liver Transplant: A Systems-Based Analysis of Health Care Utilization.

Russell TA, Angarita SAK, Showen A, Agopian V, Busuttil RW, Kaldas FM.

Am Surg. 2017 Oct 1;83(10):1152-1156.

PMID:
29391114
21.

Evaluation of Early Allograft Function Using the Liver Graft Assessment Following Transplantation Risk Score Model.

Agopian VG, Harlander-Locke MP, Markovic D, Dumronggittigule W, Xia V, Kaldas FM, Zarrinpar A, Yersiz H, Farmer DG, Hiatt JR, Busuttil RW.

JAMA Surg. 2018 May 1;153(5):436-444. doi: 10.1001/jamasurg.2017.5040. Erratum in: JAMA Surg. 2018 May 1;153(5):498.

22.

Stereotactic body radiotherapy (SBRT) for locally advanced extrahepatic and intrahepatic cholangiocarcinoma.

Sandler KA, Veruttipong D, Agopian VG, Finn RS, Hong JC, Kaldas FM, Sadeghi S, Busuttil RW, Lee P.

Adv Radiat Oncol. 2016 Oct 29;1(4):237-243. doi: 10.1016/j.adro.2016.10.008. eCollection 2016 Oct-Dec.

23.

Determination of hepatocellular carcinoma grade by needle biopsy is unreliable for liver transplant candidate selection.

Court CM, Harlander-Locke MP, Markovic D, French SW, Naini BV, Lu DS, Raman SS, Kaldas FM, Zarrinpar A, Farmer DG, Finn RS, Sadeghi S, Tomlinson JS, Busuttil RW, Agopian VG.

Liver Transpl. 2017 Sep;23(9):1123-1132. doi: 10.1002/lt.24811.

24.

Pneumonia after liver transplantation.

Angarita SAK, Russell TA, Kaldas FM.

Curr Opin Organ Transplant. 2017 Aug;22(4):328-335. doi: 10.1097/MOT.0000000000000427. Review.

PMID:
28542110
25.

Peritransplant pancreatitis: A marker of high mortality and graft failure in liver transplant patients.

Russell TA, Park S, Agopian VG, Zarrinpar A, Farmer DG, O'Neill S, Korayem I, Ebaid S, Gornbein J, Busuttil RW, Kaldas FM.

Liver Transpl. 2017 Jul;23(7):925-932. doi: 10.1002/lt.24760.

26.

Evaluation of Patients With Hepatocellular Carcinomas That Do Not Produce α-Fetoprotein.

Agopian VG, Harlander-Locke MP, Markovic D, Zarrinpar A, Kaldas FM, Cheng EY, Yersiz H, Farmer DG, Hiatt JR, Busuttil RW.

JAMA Surg. 2017 Jan 1;152(1):55-64. doi: 10.1001/jamasurg.2016.3310.

27.

Avoiding Futility in Simultaneous Liver-kidney Transplantation: Analysis of 331 Consecutive Patients Listed for Dual Organ Replacement.

Lunsford KE, Bodzin AS, Markovic D, Zarrinpar A, Kaldas FM, Gritsch HA, Xia V, Farmer DG, Danovitch GM, Hiatt JR, Busuttil RW, Agopian VG.

Ann Surg. 2017 May;265(5):1016-1024. doi: 10.1097/SLA.0000000000001801.

PMID:
27232249
28.

Individualizing liver transplant immunosuppression using a phenotypic personalized medicine platform.

Zarrinpar A, Lee DK, Silva A, Datta N, Kee T, Eriksen C, Weigle K, Agopian V, Kaldas F, Farmer D, Wang SE, Busuttil R, Ho CM, Ho D.

Sci Transl Med. 2016 Apr 6;8(333):333ra49. doi: 10.1126/scitranslmed.aac5954.

29.

Incidence and risk factors for deep venous thrombosis and pulmonary embolus after liver transplantation.

Emuakhagbon V, Philips P, Agopian V, Kaldas FM, Jones CM.

Am J Surg. 2016 Apr;211(4):768-71. doi: 10.1016/j.amjsurg.2015.11.028. Epub 2016 Jan 6.

PMID:
26852631
30.

Damage Control as a Strategy to Manage Postreperfusion Hemodynamic Instability and Coagulopathy in Liver Transplant.

DiNorcia J, Lee MK, Harlander-Locke MP, Xia V, Kaldas FM, Zarrinpar A, Farmer DG, Yersiz H, Hiatt JR, Busuttil RW, Agopian VG.

JAMA Surg. 2015 Nov;150(11):1066-72. doi: 10.1001/jamasurg.2015.1853.

PMID:
26308380
31.

Complete pathologic response to pretransplant locoregional therapy for hepatocellular carcinoma defines cancer cure after liver transplantation: analysis of 501 consecutively treated patients.

Agopian VG, Morshedi MM, McWilliams J, Harlander-Locke MP, Markovic D, Zarrinpar A, Kaldas FM, Farmer DG, Yersiz H, Hiatt JR, Busuttil RW.

Ann Surg. 2015 Sep;262(3):536-45; discussion 543-5. doi: 10.1097/SLA.0000000000001384.

PMID:
26258323
32.

Treating fibrosing cholestatic hepatitis C with sofosbuvir and ribavirin: a matched analysis.

Saab S, Jimenez M, Bau S, Goo T, Zhao D, Durazo F, Han S, El Kabany M, Kaldas F, Tong MJ, Busuttil RW.

Clin Transplant. 2015 Sep;29(9):813-9. doi: 10.1111/ctr.12584. Epub 2015 Aug 21.

PMID:
26147216
33.

A rapid, reproducible, noninvasive predictor of liver graft survival.

Zarrinpar A, Lee C, Noguchi E, Yersiz H, Agopian VG, Kaldas FM, Farmer DG, Busuttil RW.

J Surg Res. 2015 Jul;197(1):183-90. doi: 10.1016/j.jss.2015.03.093. Epub 2015 Apr 7.

34.

Procurement strategies for combined multiorgan and composite tissues for transplantation.

Datta N, Yersiz H, Kaldas F, Azari K.

Curr Opin Organ Transplant. 2015 Apr;20(2):121-6. doi: 10.1097/MOT.0000000000000172. Review.

PMID:
25856175
35.

A novel prognostic nomogram accurately predicts hepatocellular carcinoma recurrence after liver transplantation: analysis of 865 consecutive liver transplant recipients.

Agopian VG, Harlander-Locke M, Zarrinpar A, Kaldas FM, Farmer DG, Yersiz H, Finn RS, Tong M, Hiatt JR, Busuttil RW.

J Am Coll Surg. 2015 Apr;220(4):416-27. doi: 10.1016/j.jamcollsurg.2014.12.025. Epub 2014 Dec 27.

PMID:
25690672
36.

Reoperative complications after primary orthotopic liver transplantation: a contemporary single-center experience in the post-model for end-stage liver disease era.

DiNorcia J, Lee MK, Harlander-Locke M, Zarrinpar A, Kaldas FM, Yersiz H, Farmer DG, Hiatt JR, Busuttil RW, Agopian VG.

J Am Coll Surg. 2014 Nov;219(5):993-1000. doi: 10.1016/j.jamcollsurg.2014.07.005. Epub 2014 Jul 16.

PMID:
25127506
37.

Liver transplantation in recipients receiving renal replacement therapy: outcomes analysis and the role of intraoperative hemodialysis.

Agopian VG, Dhillon A, Baber J, Kaldas FM, Zarrinpar A, Farmer DG, Petrowsky H, Xia V, Honda H, Gornbein J, Hiatt JR, Busuttil RW.

Am J Transplant. 2014 Jul;14(7):1638-47. doi: 10.1111/ajt.12759. Epub 2014 May 22.

38.

Liver transplantation in highest acuity recipients: identifying factors to avoid futility.

Petrowsky H, Rana A, Kaldas FM, Sharma A, Hong JC, Agopian VG, Durazo F, Honda H, Gornbein J, Wu V, Farmer DG, Hiatt JR, Busuttil RW.

Ann Surg. 2014 Jun;259(6):1186-94. doi: 10.1097/SLA.0000000000000265.

PMID:
24263317
39.

Liver transplantation in children using organ donation after circulatory death: a case-control outcomes analysis of a 20-year experience in a single center.

Hong JC, Venick R, Yersiz H, Kositamongkol P, Kaldas FM, Petrowsky H, Farmer DG, Agopian V, McDiarmid SV, Hiatt JR, Busuttil RW.

JAMA Surg. 2014 Jan;149(1):77-82. doi: 10.1001/jamasurg.2013.3195.

PMID:
24257966
40.

The evolution of liver transplantation during 3 decades: analysis of 5347 consecutive liver transplants at a single center.

Agopian VG, Petrowsky H, Kaldas FM, Zarrinpar A, Farmer DG, Yersiz H, Holt C, Harlander-Locke M, Hong JC, Rana AR, Venick R, McDiarmid SV, Goldstein LI, Durazo F, Saab S, Han S, Xia V, Hiatt JR, Busuttil RW.

Ann Surg. 2013 Sep;258(3):409-21. doi: 10.1097/SLA.0b013e3182a15db4.

41.

Liver transplantation for lethal genetic syndromes: a novel model of personalized genomic medicine.

Petrowsky H, Brunicardi FC, Leow VM, Venick RS, Agopian V, Kaldas FM, Zarrinpar A, Markovic D, McDiarmid SV, Hong JC, Farmer DG, Hiatt JR, Busuttil RW.

J Am Coll Surg. 2013 Apr;216(4):534-43; discussion 543-4. doi: 10.1016/j.jamcollsurg.2012.12.050.

PMID:
23521929
42.

Blood transfusion requirement during liver transplantation is an important risk factor for mortality.

Rana A, Petrowsky H, Hong JC, Agopian VG, Kaldas FM, Farmer D, Yersiz H, Hiatt JR, Busuttil RW.

J Am Coll Surg. 2013 May;216(5):902-7. doi: 10.1016/j.jamcollsurg.2012.12.047. Epub 2013 Mar 9.

PMID:
23478547
43.

Assessment of hepatic steatosis by transplant surgeon and expert pathologist: a prospective, double-blind evaluation of 201 donor livers.

Yersiz H, Lee C, Kaldas FM, Hong JC, Rana A, Schnickel GT, Wertheim JA, Zarrinpar A, Agopian VG, Gornbein J, Naini BV, Lassman CR, Busuttil RW, Petrowsky H.

Liver Transpl. 2013 Apr;19(4):437-49. doi: 10.1002/lt.23615. Epub 2013 Mar 17.

44.

Management of recurrent hepatocellular carcinoma in liver transplant recipients: a systematic review.

Rubin J, Ayoub N, Kaldas F, Saab S.

Exp Clin Transplant. 2012 Dec;10(6):531-43. Review.

45.

Twenty-four years after liver transplantation, the recipient becomes a body donor.

Petrowsky H, Kaldas F, Peacock W, Fisher D, Hong JC, Lassman C, Busuttil RW.

Liver Transpl. 2013 Jan;19(1):110-2. doi: 10.1002/lt.23560. No abstract available.

46.

Liver transplantation for nonalcoholic steatohepatitis: the new epidemic.

Agopian VG, Kaldas FM, Hong JC, Whittaker M, Holt C, Rana A, Zarrinpar A, Petrowsky H, Farmer D, Yersiz H, Xia V, Hiatt JR, Busuttil RW.

Ann Surg. 2012 Oct;256(4):624-33. doi: 10.1097/SLA.0b013e31826b4b7e.

PMID:
22964732
47.

Liver transplantation using organ donation after cardiac death: a clinical predictive index for graft failure-free survival.

Hong JC, Yersiz H, Kositamongkol P, Xia VW, Kaldas FM, Petrowsky H, Farmer DG, Lipshutz G, Markovic D, Hiatt JR, Busuttil RW.

Arch Surg. 2011 Sep;146(9):1017-23. doi: 10.1001/archsurg.2011.240.

PMID:
21930997
48.

Predictive index for long-term survival after retransplantation of the liver in adult recipients: analysis of a 26-year experience in a single center.

Hong JC, Kaldas FM, Kositamongkol P, Petrowsky H, Farmer DG, Markovic D, Hiatt JR, Busuttil RW.

Ann Surg. 2011 Sep;254(3):444-8; discussion 448-9. doi: 10.1097/SLA.0b013e31822c5878.

PMID:
21817890
49.

Liver transplantation for hepatocellular carcinoma: an update.

Zarrinpar A, Kaldas F, Busuttil RW.

Hepatobiliary Pancreat Dis Int. 2011 Jun;10(3):234-42. Review.

PMID:
21669564
50.

Predictive index for tumor recurrence after liver transplantation for locally advanced intrahepatic and hilar cholangiocarcinoma.

Hong JC, Petrowsky H, Kaldas FM, Farmer DG, Durazo FA, Finn RS, Saab S, Han SH, Lee P, Markovic D, Lassman C, Hiatt JR, Busuttil RW.

J Am Coll Surg. 2011 Apr;212(4):514-20; discussion 520-1. doi: 10.1016/j.jamcollsurg.2010.12.005.

PMID:
21463781

Supplemental Content

Loading ...
Support Center